Your browser doesn't support javascript.
loading
Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers.
Murciano-Goroff, Yonina R; Pak, Terry; Mondaca, Sebastian; Flynn, Jessica R; Montecalvo, Joseph; Rekhtman, Natasha; Halpenny, Darragh; Plodkowski, Andrew J; Wu, Stephanie L; Kris, Mark G; Paik, Paul K; Riely, Gregory J; Yu, Helena A; Rudin, Charles M; Hellmann, Matthew D; Land, Josiah D; Buie, Larry W; Heller, Glenn; Lito, Piro; Yaeger, Rona; Drilon, Alexander; Liu, Dazhi; Li, Bob T; Offin, Michael.
Affiliation
  • Murciano-Goroff YR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Pak T; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mondaca S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Flynn JR; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Montecalvo J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rekhtman N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Halpenny D; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wu SL; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Paik PK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yu HA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Land JD; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Buie LW; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Heller G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lito P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Liu D; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Offin M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. offinm@mskcc.org.
Br J Cancer ; 126(6): 889-898, 2022 04.
Article in En | MEDLINE | ID: mdl-34963703
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Proto-Oncogene Proteins B-raf / Immune Checkpoint Inhibitors / Lung Neoplasms Limits: Humans Language: En Journal: Br J Cancer Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Proto-Oncogene Proteins B-raf / Immune Checkpoint Inhibitors / Lung Neoplasms Limits: Humans Language: En Journal: Br J Cancer Year: 2022 Type: Article Affiliation country: United States